SAN FRANCISCO, June 27 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, will join the Russell Microcap Index when Russell Investments reconstitutes its family of U.S. indexes on June 27 after market close, according to a preliminary list of additions posted on http://www.russell.com
"We are pleased to have been selected for inclusion in this objective, market-driven index as we believe it reflects our continued progress and potential," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals.
Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000 Index and Russell Microcap. Total returns data for the Russell Microcap and other Russell Indexes is available at http://www.russell.com/Indexes/performance/daily_total_returns_us.asp.
Russell Investments aims to improve financial security for people by
providing strategic advice, world-class implementation, state-of-the-art
performance benchmarks, and a range of institutional-quality investment
products. With more than $213 billion in assets under management,
|SOURCE VIA Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved